Gold Daniel Allen's Form 4 filing
Roivant Sciences Ltd. (ROIV) · filed Oct 2, 2023
- Accession no.
- 0000899243-23-019661
- Filed
- Oct 2, 2023
- Trade date
- Sep 28, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions. Open-market sales total $115.5M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gold Daniel AllenCIK 0001832142 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 28, 2023 | Common Shares | SSaleDisposed | −8,957 | $11.55 | −$103,453.35 | 100,804 | Indirect | |
| Sep 28, 2023 | Common Shares | SSaleDisposed | −2,285,783 | $11.55 | −$26,400,793.65 | 25,724,561 | Indirect | |
| Sep 28, 2023 | Common Shares | SSaleDisposed | −3,059,368 | $11.55 | −$35,335,700.4 | 34,430,591 | Indirect | |
| Sep 28, 2023 | Common Shares | SSaleDisposed | −3,094,899 | $11.55 | −$35,746,083.45 | 34,830,463 | Indirect | |
| Sep 28, 2023 | Common Shares | SSaleDisposed | −1,104,599 | $11.55 | −$12,758,118.45 | 12,431,330 | Indirect | |
| Sep 28, 2023 | Common Shares | SSaleDisposed | −446,394 | $11.55 | −$5,155,850.7 | 5,023,787 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.